Mindfulness may soothe psoriasis stress

NCT ID NCT07615257

First seen Jun 25, 2026 · Last updated Jun 25, 2026

Summary

This study tests whether Mindfulness-Based Cognitive Therapy (MBCT) can reduce psychological distress and improve self-compassion in people with psoriasis. Researchers will enroll 128 adults with psoriasis who are experiencing emotional difficulties. Participants will either receive MBCT sessions or continue with usual care, and the study will measure changes in distress, self-compassion, and how much control they feel over their health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Dermatologist Sheikh Zayed Hospital Rahim Yar Khan

    RECRUITING

    Rahim Yar Khan, Punjab Province, 64200, Pakistan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Mindfulness-Based Cognitive Therapy (MBCT)

What this could lead to

If it works, this could point toward a low-cost, drug-free way to ease the emotional burden of psoriasis and improve patients' quality of life.

What could go wrong

This is a small, early-stage behavioral study with no blinding. Results may not apply to all psoriasis patients, and the effect on physical symptoms is not being measured.

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.